Insights

2 compelling ASX 200 blue chip shares to buy in February

CSL Limited (ASX:CSL) and this other compelling ASX blue chip share could be the ones to buy in February…
The post 2 compelling ASX 200 blue chip shares to buy in February appeared first on The Motley Fool Australia. –

blackboard drawing of hand pointing to the words buy now

The S&P/ASX 200 Index (ASX: XJO) is home to a good number of shares with true blue chip status.

But given the numerous choices that investors have, it can be hard to decide which ones to include in your portfolio.

In order to narrow things down, I have picked out two blue chip ASX 200 shares which are highly rated right now. They are as follows:

CSL Limited (ASX: CSL)

The first ASX 200 blue chip share to consider is CSL. It is one of the world’s leading biotechnology company, responsible for the CSL Behring and Seqirus businesses.

These two businesses are leaders in their respective fields and have a combined portfolio of life-saving and lucrative therapies and vaccines which are generating billions of dollars in sales each year.

But management doesn’t rest on its laurels. Each year, the company reinvests approximately 10% to 11% of its sales back into research and development activities. This means it is on course to invest around US$1 billion into these activities this year. This ensures that it remains at the forefront of innovation and has a pipeline full of potentially lucrative products.

The CSL share price has come under pressure in recent months due to concerns about plasma collections. Plasma is a key ingredient in many of its therapies and COVID-19 is making it difficult to collect. This appears to be driving up prices and is likely to hit the margins of its immunoglobulin products in the future.

Nevertheless, this should be a relatively short term headwind and offset somewhat by increased demand for flu vaccines made by Seqirus.

Analysts at UBS believe the weakness in the CSL share price is a buying opportunity. They have recently reaffirmed their buy rating and $346.00 price target on its shares.

Goodman Group (ASX: GMG)

Another ASX 200 blue chip share to look at is Goodman Group. It is an integrated commercial and industrial property group that owns, develops, and manages industrial real estate across the world.

Goodman has been a very impressive performer over the last decade and has generated strong total returns for shareholders.

This has been underpinned by management’s highly successful focus on “investing in and developing high quality industrial properties in strategic locations, close to large urban populations and in and around major gateway cities globally, where demand is strong and transformational changes are driving significant opportunities” for its business.

Among its customers are fellow blue chips such as Amazon, Coles Group Ltd (ASX: COL), DHL, and Walmart, to name just four.

One broker that is positive on the company’s performance and its growth prospects is Morgan Stanley. It currently has an overweight rating and $20.90 price target on its shares.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of June 30th

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of COLESGROUP DEF SET. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 compelling ASX 200 blue chip shares to buy in February appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!